Results 21 to 30 of about 59,490 (296)

Case series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reports

open access: yesJournal of Medical Case Reports, 2021
Background Atypical hemolytic uremic syndrome is an exceedingly rare thrombotic microangiopathy caused by accelerated activation of the alternative complement pathway.
Christine J. Kurian   +7 more
doaj   +1 more source

Clostridioides difficile-Associated Atypical Hemolytic-Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review

open access: yesCritical Care Explorations, 2021
BACKGROUND:. Clostridioides difficile infection is a rare precipitant for patients to develop atypical hemolytic-uremic syndrome, of which the pathogenesis remains unclear. Previous reports suggest activation of cytokine storm from binding of cyotoxins A
Michael N. Moulton, DO   +4 more
doaj   +1 more source

Delayed‐Onset Hemolysis in a Case of Hemolytic Uremic Syndrome: A Diagnostic Challenge [PDF]

open access: yesCase Reports in Hematology
Background Hemolytic uremic syndrome is a rare thrombotic microangiopathy characterized by hemolytic anemia, thrombocytopenia, and acute kidney injury. While commonly reported in children, adult‐onset presentations are less frequent and often atypical, leading to diagnostic delays.
Younas M, Fatima N, Naveed Z, Nafisa S.
europepmc   +2 more sources

Pediatric Atypical Hemolytic Uremic Syndrome Advances

open access: yesCells, 2021
Atypical hemolytic uremic syndrome (aHUS) is a rare disorder characterized by dysregulation of the alternate pathway. The diagnosis of aHUS is one of exclusion, which complicates its early detection and corresponding intervention to mitigate its high ...
R. Raina   +9 more
semanticscholar   +1 more source

Neurological involvement in children with hemolytic uremic syndrome

open access: yesEuropean Journal of Pediatrics, 2021
Our objective was to establish the rate of neurological involvement in Shiga toxin-producing Escherichia coli–hemolytic uremic syndrome (STEC-HUS) and describe the clinical presentation, management and outcome.
C. Costigan   +17 more
semanticscholar   +1 more source

Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in a renal transplant recipient case report

open access: yesBrazilian Journal of Nephrology, 2020
Thrombotic microangiopathies are disorders characterized by nonimmune microangiopathic hemolytic anemia, thrombocytopenia, and multi-systemic failure.
John Fredy Nieto-Rios   +7 more
doaj   +2 more sources

Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review

open access: yesToxins, 2020
The severity of human infection by one of the many Shiga toxin-producing Escherichia coli (STEC) is determined by a number of factors: the bacterial genome, the capacity of human societies to prevent foodborne epidemics, the medical condition of infected
Adrien Joseph   +4 more
semanticscholar   +1 more source

Hemolytic uremic syndrome (HUS) – case report

open access: yesJournal of Education, Health and Sport, 2020
Introduction Hemolytic uremic syndrome (HUS) is characterized by hemolytic anemia, thrombocytopenia and acute renal failure. In 90% of children, HUS most often develops after an intestinal infection caused by verotoxin-producing E. coli. The remaining 10%
Aleksandra Borkowska   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy